Drug Trial Radar · NCT02426775
Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia
Last checked: Nov 20, 2026Latest source record: Apr 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
33
Actual
Start
Nov 2015
Primary completion
Mar 19, 2019
Study completion Mar 19, 2019
Sponsor
- Lead sponsor
- King Abdullah International Medical Research CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 27, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 15 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase IIIb (Three b), Randomized Multicentre Comparative Trial to Evaluate the Long Term Effectiveness \& Safety of the use of Carglumic Acid (Carbaglu®) in Patients with Propionic Acidemia (PA) or Methylmalonic Acidemia (MMA). Carbaglu® clinical experience in Organic Acidemia (OA) is limited to a non-comparative retrospective collection of data from patients who had received Carbaglu® for 1 to 15 days. There is no current evidence supporting the use of carglumic acid for the chronic management of patients with OA. The investigators are proposing a randomized multicentre prospective clinical trial to evaluate long-term effects of the use of Carbaglu® (50mg/kg/day) combined with standard chronic therapy in patients with PA and MMA compared to standard chronic therapy alone.
Conditions
- Propionic Acidemia
- Methylmalonic Acidemia
Interventions
Carglumic AcidDrug
Carglumic Acid 50 mg/kg/day (twice daily)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of emergency visits due to hyperammonemia within 24 months periodTime frame: 24 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
King Abdullah Specialist Children Hospital, King Abdulaziz Medical City
Riyadh, Saudi Arabia
King Fahad Medical City
Riyadh, Saudi Arabia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.